JOHN CHIDSEY
CIK 1128484 · President and CEO · last filed 2026-05-26
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$48.90M
Companies
7
Total Filings
132
Lifetime Open-Market Net
-$8.22M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| NCLH | President and CEO | 1,139,940 | $18.55 | $21.15M | $2.50M | 12 | 2026-05-26 |
| HCA | Director | 1,308 | $414.03 | $541.6K | $0 | 2 | 2026-04-30 |
| EHC | Director | 162,592 | $125.81 | $20.46M | $0 | 35 | 2024-04-16 |
| EAT | Director | 1,890 | $227.54 | $430.1K | $0 | 1 | 2019-02-11 |
| Encompass Health Corp (HLS) Delisted | Director | 102,921 | — | — | $0 | 52 | 2017-10-18 |
| Encompass Health Corp (HLS.WS) Delisted | Director | 96,218 | — | — | $28.6K | 7 | 2016-10-19 |
| WMG | Chief Executive Officer | 239,654 | $26.41 | $6.33M | -$10.75M | 22 | 2010-10-19 |
Recent Filings · Page 9 of 14
132 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2013-04-09 | Encompass Health Corp (HLS) Delisted | Grant (A) | +1,076 | $28.1K | EDGAR |
| 2013-04-02 | NCLH | Grant (A) | +6,683 | $0 | EDGAR |
| 2013-02-19 | Encompass Health Corp (HLS) Delisted | Grant (A) | +5,118 | $0 | EDGAR |
| 2013-01-09 | Encompass Health Corp (HLS) Delisted | Grant (A) | +1,262 | $28.1K | EDGAR |
| 2012-10-04 | Encompass Health Corp (HLS) Delisted | Grant (A) | +1,175 | $28.2K | EDGAR |
| 2012-07-06 | Encompass Health Corp (HLS) Delisted | Other (J) | +1,210 | $28.2K | EDGAR |
| 2012-04-12 | Encompass Health Corp (HLS) Delisted | Other (J) | +1,420 | $28.5K | EDGAR |
| 2012-02-27 | Encompass Health Corp (HLS) Delisted | Grant (A) | +4,767 | $0 | EDGAR |
| 2012-01-09 | Encompass Health Corp (HLS) Delisted | Other (J) | +1,620 | $28.4K | EDGAR |
| 2011-10-07 | Encompass Health Corp (HLS) Delisted | Other (J) | +1,908 | $28.2K | EDGAR |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.